MDHearing Volt vs ReSound OMNIA miniRIE

The MDHearing Volt is a budget-priced prescription hearing aid released in 2020, earning a B grade with a SoundScore of 3.0/5 in our lab testing. At $397, it sits in the lowest price tier for prescription devices, ranking #34 of 39 in its category. In our testing, the Volt showed a mixed performance profile with one standout strength: feedback handling scored an excellent 5.0/5, which is 0.28 points above the category average. This means users can expect minimal whistling or squealing during typical wear. However, speech performance was limited, with speech in quiet scoring 1.8/5 (1.65 points below average) and speech in noise at 1.0/5 (1.11 points below average). Own voice comfort was mixed at 2.6/5, roughly matching the category average. Music streaming capability was not functional in our testing, scoring 0.0/5—a significant limitation for users who want to stream audio from their phone. This is 2.76 points below the prescription hearing aid category average. The Volt may appeal to budget-conscious consumers who prioritize basic amplification and feedback-free wear over advanced speech enhancement or streaming features. Those seeking stronger speech performance in the same price range may want to consider alternatives like the RxEars Rxi, which scored 4.07/5 in our testing. The Volt's rechargeable battery and behind-the-ear design offer practical convenience, but its core sound performance reflects its entry-level positioning.

The ReSound OMNIA miniRIE is a premium prescription behind-the-ear hearing aid released in 2022, priced at $4,764. In our lab testing, it earned a SoundScore of 4.0/5 (A grade), ranking #26 of 39 prescription hearing aids tested. This device demonstrates solid speech clarity in quiet environments, scoring 3.7/5—0.26 points above the category average. Own-voice comfort also measures slightly above average at 2.9/5. However, the OMNIA miniRIE struggles in challenging listening situations, with speech-in-noise performance scoring just 1.0/5, which is 1.11 points below the category average and low in absolute terms. This represents a significant limitation for users who frequently encounter noisy environments like restaurants or social gatherings. Feedback handling is strong in absolute terms at 4.1/5, though this falls 0.62 points below the prescription hearing aid category average of 4.72/5. Music streaming performance is mixed at 2.7/5, essentially matching the category average. The device offers modern connectivity features including iPhone and Android streaming, hands-free calling, and rechargeable batteries. While the OMNIA miniRIE has earned Expert's Choice Awards in 2023 and 2024, consumers in this premium price tier should note that several competitors—including the Phonak Sphere Infinio and Oticon Intent—achieve higher overall scores. This hearing aid may be best suited for individuals who prioritize performance in quieter settings and value ReSound's ecosystem, but those needing robust noise management should explore alternatives.